Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Variation Biotechnologies

Explore full profile

Variation Biotechnologies Inc, an Ottawa, Canada-based maker of vaccines for infectious diseases

Cambridge, United StatesFounded 2001Biotech & Life Sciences
Valuation $100–250M Last recorded · 2007
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Variation Biotechnologies and the history behind them.

At a glance

Status
Operational
Founded
2001
Headquarters
Cambridge, United States
Employees
46
Open positions
None listed
Dealroom signal
26.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Vaccines, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b
Links
WebsiteX

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2007 $36M $143M 5AM Ventures · Clarus Ventures · ARCH Venture Partners —
SPINOUT✓Other financing Jan 2001 $0 — Laval University —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Variation Biotechnologies website traffic

Latest recorded traffic for Variation Biotechnologies is 41K monthly website visits. Variation Biotechnologies's team grew 9.5% over the past year.

Latest monthly visits41K 1-year team growth+9.5%
Monthly website visitsApr 2016–Jan 2021
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Uvax BioInnovative vaccine solutions leveraging proprietary 1c SA p platform technology for HIV and other infectious diseases Newark, United States Operational 6 $14M $44M
Solaris VaccinesA biotechnology company that develops therapeutic vaccines for infectious diseases Fort Collins, United States Operational
ManaAn AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy Tel Aviv-Yafo, Israel Operational
Entos PharmaceuticalsDeveloping next-generation genetic medicines using their proprietary Fusogenix drug delivery platform Edmonton, Canada Operational
DesentumBiopharma company in Finland developing allergy vaccines that change the way the immune system reacts to allergens Espoo, Finland Operational
IcosavaxDeveloping safe and effective vaccines against infectious diseases that cause severe, life-threatening respiratory illnesses Seattle, United States Acquired
DentericDeveloping vaccines for treating and preventing severe periodontal disease, with the ultimate goal of improving the health of people with this disease Melbourne, Australia Operational
PulmobioticsDiscovers and develops novel treatments and vaccines for respiratory diseases Barcelona, Spain Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Other known investors1 additional known investor

  • Laval University

Talent

Book a demo to see the people
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Variation Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Variation Biotechnologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.